New Zealand markets closed

GRAIL, LLC (GRALV)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
18.63+1.41 (+8.19%)
At close: 04:00PM EDT
Full screen
Loading interactive chart…
  • Investing.com

    Gene-sequencing group Illumina sees $1.47 bn Q2 impairment charge linked to Grail

    Investing.com -- Gene-sequencing firm Illumina (NASDAQ:ILMN) said it would take goodwill impairment charge of $1.47 billion in its second quarter linked to its recently spun-off cancer diagnostic test manufacturer Grail (NASDAQ:GRAL).

  • Reuters

    Illumina to take $1.47 billion goodwill impairment charge related to Grail in Q2

    Gene-sequencing equipment maker Illumina said it will likely recognize an additional impairment charge of about $420 million for Grail's in-process research and development intangible (IPR&D) asset in the quarter ended June. In December, activist investor Carl Icahn said Grail's greater-than-expected expenditure and delays in advancing its tests had also forced Illumina to take impairments that totaled $4.7 billion.